{"doi":"10.1016/j.ejmech.2020.113013","title":"Discovery of tetrahydroquinolines and benzomorpholines as novel potent RORγt agonists","abstract":null,"journal":"European Journal of Medicinal Chemistry","year":2021,"id":14273,"datarank":0.6041947665751092,"base_score":3.332204510175204,"endowment":3.332204510175204,"self_citation_contribution":0.49983067652628066,"citation_network_contribution":0.10436409004882856,"self_endowment_contribution":0.49983067652628066,"citer_contribution":0.10436409004882856,"corpus_percentile":null,"corpus_rank":null,"citation_count":27,"citer_count":6,"citers_with_citation_signal":4,"citers_with_endowment":4,"datacite_reuse_total":14,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":113526,"name":"Mingcheng Yu","orcid":null,"position":1,"is_corresponding":false},{"id":113527,"name":"Yunpeng Zhao","orcid":null,"position":2,"is_corresponding":false},{"id":113528,"name":"Li Xia","orcid":null,"position":3,"is_corresponding":false},{"id":113517,"name":"Yafei Huang","orcid":null,"position":4,"is_corresponding":false},{"id":111897,"name":"Nannan Sun","orcid":null,"position":5,"is_corresponding":false},{"id":113529,"name":"Meiqi Song","orcid":null,"position":6,"is_corresponding":false},{"id":113530,"name":"Huimin Guo","orcid":null,"position":7,"is_corresponding":false},{"id":113531,"name":"Yunyi Zhang","orcid":null,"position":8,"is_corresponding":false},{"id":113532,"name":"Di Zhu","orcid":null,"position":9,"is_corresponding":false},{"id":111898,"name":"Qiong Xie","orcid":"0000-0002-1801-4561","position":10,"is_corresponding":false},{"id":73841,"name":"Yonghui Wang","orcid":"0000-0002-0262-2431","position":11,"is_corresponding":false},{"id":113525,"name":"Yuehan Xia","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.332204510175204,"endowment":3.332204510175204,"datacite_reuse_total":14,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33272782","pmcid":null,"openalex_id":"https://openalex.org/W3104755569","authors":[],"funders":[{"funder_name":"China Postdoctoral Science Foundation","grant_id":"","title":null},{"funder_name":"Science and Technology Commission of Shanghai Municipality","grant_id":"","title":null},{"funder_name":"National Science and Technology Major Project","grant_id":"","title":null},{"funder_name":"National Natural Science Foundation of China","grant_id":"","title":null},{"funder_name":"Natural Science Foundation of Shanghai","grant_id":"","title":null}],"total_grants":5,"fwci":1.8686,"citation_percentile":0.86809299,"influential_citations":0,"citation_trend":[{"year":2021,"count":3},{"year":2022,"count":17},{"year":2023,"count":3},{"year":2025,"count":4}],"oa_status":"green","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://doi.org/10.7270/q2bz69t4","host_type":"repository"},{"url":"https://doi.org/10.7270/q2bz69t4","host_type":"repository"},{"url":"https://api.elsevier.com/content/article/PII:S0223523420309855?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0223523420309855?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.ejmech.2020.113013","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33272782","host_type":"repository"}],"fields_of_study":["Psoriasis: Treatment and Pathogenesis","IL-33, ST2, and ILC Pathways","Autoimmune Bullous Skin Diseases","Medicine","Chemistry","Animals","Cell Differentiation","Dose-Response Relationship, Drug","Drug Discovery","Humans","Mice","Molecular Docking Simulation","Molecular Structure","Morpholines","Nuclear Receptor Subfamily 1, Group F, Member 3","Quinolines","Structure-Activity Relationship","Th17 Cells"],"mesh_terms":["Animals","Cell Differentiation","Dose-Response Relationship, Drug","Humans","Morpholines","Quinolines","Structure-Activity Relationship","Molecular Structure","Mice","Drug Discovery","Nuclear Receptor Subfamily 1, Group F, Member 3","Th17 Cells","Molecular Docking Simulation"],"keywords":["RAR-related orphan receptor gamma","Chemistry","Nuclear receptor","Agonist","Orphan receptor","Inverse agonist","Linker","Reporter gene","Stereochemistry","Partial agonist","Receptor","Coactivator","Pharmacology","Biochemistry","Gene expression","Transcription factor","Gene","Cancer Immunotherapy","Tetrahydroquinolines","Functional Switch","Rorγt Agonists","Benzomorpholines"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.19641892.v1","title":"Additional file 1 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641892","title":"Additional file 1 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641895.v1","title":"Additional file 2 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641895","title":"Additional file 2 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641898.v1","title":"Additional file 3 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641898","title":"Additional file 3 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641901.v1","title":"Additional file 4 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641901","title":"Additional file 4 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641904.v1","title":"Additional file 5 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641904","title":"Additional file 5 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641907.v1","title":"Additional file 6 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641907","title":"Additional file 6 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641910.v1","title":"Additional file 7 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.19641910","title":"Additional file 7 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T07:29:06.706524Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}